GL1X · GenesisL1 explorer

MolNFT v1 · #137559 · protein

Structure of human G9A set-domain (EHMT2) in complex with inhibitor 13

5VSC: “Structure of human G9A set-domain (EHMT2) in complex with inhibitor 13”. X-ray diffraction, 2 ligands (9HJ, ZN). MolNFT v1 #137559 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5VSC
Type
protein
Length
543 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
Q96KQ7
Ligands
9HJ, ZN

Structure

x-ray diffraction · 2 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein270—Q96KQ7
B—protein273—Q96KQ7

Ligands and binding sites

  • 9HJ · 6,7-dimethoxy-N~2~-methyl-N~4~-(1-methylpiperidin-4-yl)-N~2~-propylquinazoline-2,4-diamine · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 8 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 5VSC · Structure of human G9a SET-domain (EHMT2) in complex with inhibitor 13 · the same entry in another collection · chain B against B, TM-score 1.00
  • Q96KQ7 · AlphaFold monomer V2.0 prediction for histone-lysine N-methyltransferase EHMT2 (Q96KQ7) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.